An infectious cDNA clone was constructed from the genome of coxsackievirus Bi strain. A number of RNA transcripts that have mutations in the 5' noncoding region were synthesized in vitro from the modified cDNA clones and examined for their abilities to act as mRNAs in a cell-free translation system prepared from HeLa S3 cells. RNAs that lack nucleotide sequences at positions 568 to 726 and 565 to 726 were found to be less efficient and inactive mRNAs, respectively. To understand the biological significance of this region of RNA, small deletions and point mutations were introduced in the nucleotide sequence between positions 538 and 601.
inactivate the mRNA. In the upstream region, a sequence consisting of 21 nucleotides at positions 546 to 566 is perfectly conserved in the 5' noncoding regions of enterovirus and rhinovirus genomes. These results suggest that the 7-base conserved sequence functions to maintain the efficiency of translation initiation and that the nucleotide sequence upstream of position 567, including the 21-base conserved sequence, plays essential roles in translation initiation. A deletion mutant whose genome lacks the nucleotide sequence at positions 568 to 726 showed a small-plaque phenotype and less virulence against suckling mice than the wild-type virus. Thus, reduction of the efficiency of translation initiation may result in the construction of enteroviruses with the lower-virulence phenotype.
Coxsackievirus Bi (CVB1) is a human enterovirus that belongs to the family Picornaviridae. This virus, known to be the causative agent of myositis or dilated cardiomyopathy of acute onset (14, 25) , is a nonenveloped virus containing a single-stranded RNA genome with positive polarity. To date, total nucleotide sequences of the genomes of several group B coxsackieviruses have been determined (6, 10, 16, 23) . These studies revealed that the RNAs have a fairly long (approximately 750 nucleotides) untranslated region preceding a single long open reading frame, as do other RNAs of picornaviruses. These long 5' noncoding sequences of picornavirus RNAs are thought to have essential roles in aspects of viral replication such as virus-specific RNA synthesis (1), virus-specific protein synthesis (9, 30) , and packaging.
The 5'-terminal structure of picornavirus mRNA is pUp and is not capped with m7GpppNp (4, 7, 27) . Furthermore, the mRNA harbors several AUG sequences in the 5' noncoding region (7, 39) . Thus, picornavirus mRNAs have structures unusual for eucaryotic mRNAs. Therefore, the mechanism of initiation of virus-specific protein synthesis during picornavirus replication has been considered to be quite different from that for protein synthesis by the scanning-ribosome mechanism, the initiation mechanism for most eucaryotic mRNAs (19) . Indeed, it has been proved that ribosomes directly enter an internal site of the 5' untranslated sequence of the picornavirus RNAs rather than scan the RNAs from the 5' termini (8, 9, 12, 30, 31) . This internal entry mechanism requires a substantial segment, hundreds of nucleotides long, of the 5' noncoding region of the RNAs (40) . However, details of the structure of internal ribosome entry sites have not yet been identified. Molecular genetic studies referring to structure and function of the 5' noncoding sequence have been extensively performed on the RNA of poliovirus, which is also a human enterovirus, by using infectious cDNA clones of the virus (20, 29, 33, 40) . An analysis by Kuge and Nomoto (20) of the replication process of in vitro mutants has suggested that the nucleotide sequence from positions 564 to 599 in the 5' noncoding sequence of the poliovirus genome functions to maintain the efficiency of viral replication. In this nucleotide sequence, positions 584 to 590 are perfectly conserved in the genomes of enteroviruses and rhinoviruses. One nucleotide change introduced in this 7-base sequence reduced the efficiency of translation of poliovirus (29) . Furthermore, factor p52, which was found to bind around the 7-base sequence, failed to bind the sequence mutated in this region (24) . Thus, the conserved 7-nucleotide sequence appears to retain the structure of an internal ribosome entry site required for efficient ribosome entry.
Infectious cDNA clones of polioviruses have also been employed to investigate the pathogenesis of poliovirus on a molecular level. Biological tests, including monkey neurovirulence tests with recombinant viruses composed of the virulent Mahoney and attenuated Sabin strains of type 1 poliovirus, suggested that the 5' noncoding region harbors a relatively strong determinant(s) influencing the neurovirulence or attenuation phenotype (15, 18, 28 Construction of infectious cDNA clones of CVB1. A singlestranded full-length cDNA was synthesized from the genome of CVB1 as previously described (6) and purified by alkaline agarose gel electrophoresis. Double-stranded cDNA was then synthesized by using two synthetic oligonucleotides that correspond to nucleotide sequences at positions 1 to 39 and 40 to 65 and inserted into the dephosphorylated SmaI cleavage site of cloning vector pUC18. These cDNA clones were examined for their infectivity as previously described (17) . One infectious cDNA clone was selected and designated pNI1 (Fig. 1) .
A SacI-ApaI DNA fragment of pNI1 was replaced by a synthetic oligonucleotide containing the nucleotide sequence of 410 promoter of T7 RNA polymerase followed by the sequence of the 5'-terminal region of the CVB1 genome. This plasmid was designated pNI4.
A dideoxy method was employed for determination of the nucleotide sequence of cDNAs, including the products of polymerase chain reaction (PCR).
Construction of mutant cDNA clones. To construct chimeric cDNAs composed of the Mahoney strain of type 1 poliovirus and CVB1, a XhoI-BalI (upstream of corresponding position 630) fragment of pMl(T7)0 that was renamed from pVMT7(1)DS(T) (5) was exchanged with a SalI-Bafl (upstream of corresponding position 634) fragment of pNI4, a BalI-KpnI (corresponding positions, 631 to 3664) fragment of pMl(T7)0 was exchanged with the corresponding fragment (positions 635 to 3568) of pNI4, and a fragment (downstream of the corresponding position 3665) of pMl(T7)0 was exchanged with the corresponding sequence (downstream of position 3569) of pNI4.
For constructing deletion cDNA clones pNI16 and pNI18, a PstI-BanII fragment (corresponding to nucleotides at positions 535 to 750) of pNI4 was replaced by synthetic oligonucleotides that lacked the corresponding nucleotide sequences of positions 568 to 726 and 565 to 726, respectively.
Two steps of PCR were performed by using a DNA thermal cycler (Perkin Elmer Cetus) to construct a series of mutant cDNAs, i.e., pNI32, pNI34 to pNI39, and pNI44 to pNI51. Primers A, B, and C were employed to construct each mutant cDNA. Primer A (GAGAAAACGTTCGTTAC CCGGC) has a nucleotide sequence corresponding to positions 221 to 242 of the CVB1 genome, and primer B (CACACTCTTCGGCAGAGGGGG) has a nucleotide sequence complementary to positions 951 to 971 of the genome. Primer C has a nucleotide sequence corresponding to positions 529 to 605 but carries base deletions or point mutations; for example, primer C for constructing pNI32 is TCTGCAGCGGAAACTACTTTGGGTG, which corresponds to positions 529 to 556 of the CVB1 genome but lacks three bases at positions 541 to 543. The first step of PCR was performed by using primers B (10 pmol) and C (1 pmol) with pNI4 as template. The reaction product that had a mutated sequence was purified by agarose gel electrophoresis and then elongated by the second step of PCR, using primer A (100 pmol) and the purified fragment (0.5 pmol) as primers. A PstI-ClaI fragment (corresponding to nucleotide positions 535 to 932) of pNI4 was replaced by the PCR products that had been digested with a mixture of PstI and ClaI. PCR was performed in 100 [lI of reaction mixture for 25 cycles by denaturation at 94°C for 1 min, annealing at 55°C for 1 min, and extension reaction at 72°C for 2 min with GeneAmp (DNA Amplification Reagent kit, Perkin Elmer Cetus).
Transfection. HeLa S3 monolayer cells were used for all transfection experiments in this study. DNA transfection was performed by the modified calcium phosphate method as described previously (17) . RNA transcript (1 to 5 ,ug) synthesized from cDNA clones linearized with XbaI was used for the transfection of HeLa S3 cells in a 60-mm plastic dish. RNA transfection was done by the DEAE-dextran method reported by van der Werf et al. (41) . After incubation for 3 to 7 days at 37°C, viruses were recovered from the cells as described previously (5) .
In vitro translation. Suspension-cultured HeLa S3 cells were infected with CVB1 as previously described (6) . Cytoplasmic extracts (S10) of mock-or CVB1-infected cells were prepared 3 h after the infection and were treated with micrococcal nuclease according to the method of Rose et al. (35) , with minor modifications (22) . Conditions for the translation reaction followed those reported by Rose et al. (35) . After incubation at 37°C for 1 (6) were duplicated. Direct sequence analysis of the CVB1 genome by using PCR demonstrated that these duplications actually existed in the region of the genome. Accordingly, the nucleotide-numbering system for the CVB1 genome was changed. Thus, the RNA of CVB1 consists of 7391 nucleotides without poly(A), and the virus-specific protein synthesis starts at an AUG beginning at position 743. One of the infectious cDNA clones of CVB1 thus obtained was selected and designated pNI1 (Fig. 1) . Plasmid pNI1 carries a 98-nucleotide poly(A) at the corresponding 3'-terminal region of the CVB1 genome. Specific infectivity of pNI1 was approximately 1 PFU/,Lg of DNA in HeLa S3 monolayer cells.
To obtain higher specific infectivity, we introduced +10 promoter of T7 RNA polymerase just before the CVB1 sequence of pNI1, as described in Materials and Methods (Fig. 1) . A large amount of infectious CVB1 RNA was synthesized from this plasmid (pNI4), which had been linearized by digestion with XbaI. In the RNA synthesized in vitro, two extra guanine residues should be added at the 5' end of the CVB1 RNA and 13 residues (GGGGAUCCUC UAG) should be added at the 3' end of poly(A of the genomes of the two viruses (6, 10, 16, 23) , especially in the first 650 nucleotides of the 5' noncoding region.
To know whether every genome region is exchangeable between the two viruses, we constructed a number of chimeric cDNA clones composed of infectious cDNA clones of the Mahoney strain of type 1 poliovirus [pMl(T7)0] and CVB1 (pNI4). The RNA transcripts synthesized from these chimeric cDNA clones were tested for their infectivities in HeLa S3 cells. The results indicated that only RNA transcripts from the chimeric cDNA clones pNI6 and pNI8 were infectious in HeLa S3 cells. The structures of infectious chimeric cDNAs are shown in Fig. 1 . Viruses recovered from pNI6 and pNI8 were designated Vni6 and Vni8, respectively.
To study the viability of chimeric viruses Vni6 and Vni8, AGMK cells and HeLa S3 cells were infected with these viruses (Fig. 2) . Vni6, which has CVB1 sequence in the 5' noncoding region and Mahoney sequence in the remaining genome region, shows a plaque size phenotype similar to that of the Mahoney strain [M1(T7)0] on these two cell lines. Vni8, which has a genome sequence reciprocal to that of Vni6, shows a phenotype similar to that of CVB1 (Vni4).
Furthermore, virus yields of M1(T7)0, Vni4, Vni6, and Vni8 in a single cycle of infection are almost the same in the HeLa S3 cell culture system (data not shown). Thus, the 5' noncoding sequences of both the genomes appear to be perfectly exchangeable with each other, as suggested by Johnson and Semler (11) . This observation strongly suggested that the efficiencies of the functions encoded by these regions of the two genomes are similar. It Nucleotide sequences important for viral protein synthesis. We have already constructed viable deletion mutants of poliovirus with the normal-plaque phenotype (20) , viable mutants with the small-plaque phenotype (5, 20) , and nonviable mutants (5) . The deleted genome regions and conserved nucleotide sequences (7-and 21-base sequences) in this genome region of every human enterovirus and rhinovirus are summarized in Fig. 3 . Nucleotide sequences of the genome regions of poliovirus type 1 and CVB1 were aligned such that the highest level of homology was obtained (Fig.  3) . Nucleotide positions 561, 564, and 726 of the genome of poliovirus type 1 correspond to positions 565, 568, and 726 of that of CVB1.
To know whether the functions of this genome region of CVB1 are the same as those of the corresponding region in poliovirus type 1 in viral replication, we constructed deletion cDNAs (pNI16 and pNI18) that lack the genome regions corresponding to positions 568 to 726 and 565 to 726 of the CVB1 genome, respectively, as described in Materials and Since viruses PV1(M)IC-DA21 and PV1(Sab)IC-DA21 have been shown to be less efficient in virus-specific protein synthesis in infected cells (5) , the activities of deletion RNAs of CVB1 acting as mRNAs were examined by using an in vitro translation system prepared from CVB1-infected HeLa S3 cells, as described in Materials and Methods. RNAs were transcribed in vitro from pNI16 and pNI18 that had been digested with SphI between the nucleotides corresponding to 2388 and 2389 of the CVB1 genome. The translation products labeled with [35S]methionine were analyzed by polyacrylamide gel electrophoresis (Fig. 4) . As expected, the RNA transcript from pNI16 was less-efficient mRNA than that from pNI4. RNA from pNI18 appeared not to have any ability to act as mRNA. These results strongly suggest that these sequences conserved in the genomes of enteroviruses and rhinoviruses have an important function in the internal initiation step of virus-specific protein synthesis.
Effect of modifications in nucleotide sequence on protein synthesis. To study the functions of nucleotide sequences, including the 21-and 7-base conserved sequences, as internal ribosome entry sites in virus-specific protein synthesis, 
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---= --- small deletions and point mutations were introduced in the genome region at nucleotide positions 538 to 601, as described in Materials and Methods. The structures of mutant cDNA clones thus obtained are shown in Fig. 5 . The abilities of RNA transcripts synthesized from these cDNA clones that had been digested with SphI to act as mRNAs were tested in an in vitro translation system. As shown in Fig. 6 , mutations introduced in the genome region downstream of nucleotide position 568 (pNI37, -38, -39, -48, and -50) did not have much effect on the ability of the RNA to act as mRNA, except for a nucleotide change of U to C at position 592 (pNI51). The nucleotide at position 592 is included in the 7-base conserved sequence (Fig. 5) . This observation supports our previous assumption (5, 20) , although a nucleotide change of U to A at position 590 appeared to have no effect These results strongly suggest that the 7-base conserved sequence maintains the efficiency of mRNA activity and that the nucleotide sequence upstream of position 567, including the 21-base conserved sequence, plays an essential role(s) in the internal entry of ribosomes into enterovirus and rhinovirus mRNAs.
Mouse virulence tests. Since it had been suggested by the experiments involving deletion mutants of poliovirus that a deletion mutant with a defect in the initiation of the virusspecific protein synthesis was less virulent than the parental strain (5), deletion mutant Vnil6 and parental strain Vni4 were tested for their mouse virulence as described in Materials and Methods. The results are shown in Fig. 7 (32, 34, 36) . Our preliminary mutational analysis of this possible secondary structure strongly indicated that this structure plays important roles in translation initiation. This structure in the poliovirus RNAs includes a nucleotide at position 480 of type 1 virus or position 472 of type 3 virus that has been found to be an important nucleotide for the expression of the neurovirulence phenotype of the virus (3, 15, 18, 28, 42) . This observation suggests that the reduction of efficiency of viral translation initiation results in lowered neurovirulence of poliovirus. Mouse virulence tests performed with deletion mutant Vnil6 strongly indicated that this phenomenon is also true in the case of CVB1, which has target tissues different from those of poliovirus (Fig. 7) .
Two strategies have been proposed as methods for constructing less-virulent picornaviruses (26) . One is to use the Sabin 1 strain of type 1 poliovirus as a vector carrying foreign antigenicities (18, 26) . The other is the in vitro construction of less-virulent picornaviruses by introducing into the 5' noncoding sequences of the corresponding viruses mutations that result in reduction of efficiency in certain viral replication steps (5, 26) . Both strategies for the construction of less-neurovirulent polioviruses were successfully performed. The former method, however, is difficult to be apply to the construction of chimeric viruses carrying the antigenicities of CVB1 because of a possible difference in substrate specificity of the viral proteinase 3C of poliovirus, as discussed above. Successful construction of a less-virulent CVB1 that has a long deletion in the nucleotide sequence highly conserved among the genomes of enteroviruses and rhinoviruses may indicate that the latter method is a more general one for constructing avirulent viruses. The lowervirulence phenotype provided by long deletions must be stabler than that provided by point mutations, short deletions (33), or short insertions (20) .
